Ann Arbor, MI, United States of America

Marcin Cieslik

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marcin Cieslik: Pioneering Innovations in Cancer Treatment

Introduction: Marcin Cieslik is an accomplished inventor based in Ann Arbor, MI, known for his significant contributions to cancer research and treatment. With a focus on developing targeted therapies, he holds two patents that enhance the understanding and management of cancer therapies.

Latest Patents: Cieslik's most recent patents revolve around compositions and methods for treating cancer. The first patent discusses compositions and methods specifically designed to target therapy for prostate cancer in subjects with CDK12 mutations. His second patent outlines the use of inhibitors of ARlnc1 for treating cancer, providing new approaches to combat this challenging disease.

Career Highlights: Working within the prestigious University of Michigan, Cieslik has established himself as a key figure in the field of cancer research. His innovative approaches and persistent dedication have positioned him at the forefront of cancer treatment advancements.

Collaborations: Throughout his career, Cieslik has collaborated with notable peers in the field, including Arul M. Chinnaiyan and Dan Robinson. These partnerships have been instrumental in fostering innovation and pushing the boundaries of cancer research.

Conclusion: Marcin Cieslik's work exemplifies the vital role of inventors in advancing medical science. His patents and research contributions not only aim to improve cancer treatments but also showcase the importance of collaborative efforts in the scientific community. With ongoing research and development, he continues to impact the future of cancer therapy significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…